Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 37,058 shares at $44.50 ($1.7M) on 2024-11-27, disclosed to the SEC on 2024-11-27.
Open-market sale of $1.7M PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.60 | 5,529 | $252K | 15.1% |
| 2 | $45.60 | 5,529 | $252K | 15.1% |
| 3 | $44.50 | 10,000 | $445K | 26.7% |
| 4 | $44.83 | 16,000 | $717K | 43.0% |
| Total | $44.97 avg | 37,058 | $1.7M | 100% |
| Filing → |
| PTGX | SELL | 2026-01-21 | $785K | — | Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |